What is the Impact Factor of Translational Oncology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Translational Oncology is 4.90, ranking in quartile Q2 of Web of Science (SCIE).

Is Translational Oncology indexed in Web of Science or Scopus?

Yes, Translational Oncology is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.383 (Q1) and an H-index of 84.

Who publishes Translational Oncology and what is the Article Processing Charge (APC)?

Translational Oncology is published by Neoplasia Press. The estimated Article Processing Charge (APC) is approximately $3,470 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Translational Oncology?

The official ISO-4 abbreviation of Translational Oncology is "TRANSL. ONCOL" with common acronym "tranon". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #2,820Gold OA

Translational Oncology

Acronym:tranon

•

Abbreviation (ISO):TRANSL. ONCOL

•

Identifier (ISSN):1936-5233(Print)/1944-7124(Online)

•

Publisher:Neoplasia Press

Official Website Submission Portal Compare

Clarivate IF (2026)

4.9↑ +0.8

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Translational Oncology

WoS Q2

Annual Impact Factor Metric

Current (2026):4.9

Scopus SJR & RankScopus Q1

1.383

#2,820

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

84 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate2.2%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

351articles/year

100% Gold OA•97.38% Original Research

Aims & Scope

Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.

Topics Covered (Recognized by AI)

Medicine97.5%Biology96.3%Genetics94%Internal medicine91.6%Chemistry74.9%Cancer72.3%Biochemistry71.4%Cancer research66.2%Pathology54.5%Gene48%Immunology39.8%Oncology39.2%Surgery34.8%Cell biology27%Radiology23.5%Apoptosis21.7%Physics21.1%

Primary Research Areas

Biochemistry Genetics and Molecular Biology Cancer Research

Official Website NLM PubMed Catalog Submission Portal SCImago Profile 4 Calls for Papers

4 calls

Special Issues

Calls for Papers

4 Calls for Papers · Automatically synced from ScienceDirect & publishers

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank89/333

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank88/333

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	89/333	Q2
ONCOLOGY	JCISCIE	88/333	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF4.9

Articles / Year363

Total Citations129

2025

IF4.1

Articles / Year378

Total Citations1,200

2024

IF4.5

Articles / Year396

Total Citations3,417

2023

IF5

Articles / Year241

Total Citations3,539

2022

IF4.803

Articles / Year272

Total Citations4,830

Year	Impact Factor	Articles / Year	Total Citations
2026	4.9	363	129
2025	4.1	378	1,200
2024	4.5	396	3,417
2023	5	241	3,539
2022	4.803	272	4,830
2021	4.243	321	9,830
2020	3.558	277	8,656
2019	3.138	164	4,915
2018	3.071	196	6,647
2017	—	127	4,280
2016	—	93	3,620
2015	—	68	2,161

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,820Scopus Q1SCImago Profile

Scopus Coverage:2008-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q1

1.383

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

5.03

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,470 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations4,301

3-Year Documents876

Citable Documents865

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ1

Cancer ResearchQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 2.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Translational Oncology (acronym: tranon, abbr: TRANSL. ONCOL, ISSN: 1936-5233) is a peer-reviewed international scholarly journal in the field of Biochemistry, published by Neoplasia Press in United States since 2007. The periodical holds a Journal Impact Factor (JIF) of 4.90, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.383 (Q1), an H-index of 84.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 351 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,470 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.